Skip to content

Ketamine for depression: all studies

Page 72 of 178: studies 711 to 720 of 1,775, newest first. Back to the ketamine for depression overview

Research

Lateral habenula astroglia modulate the potentiating antidepressant-like effects of bright light stimulation in intractable depression.

Frontiers in Pharmacology 2025 Sarah Delcourte, Amel Bouloufa, Renaud Rovera et al. 3 citations

Beside image vision, light plays a pivotal role in regulating diverse non-visual functions, including affective behaviors. Recently, bright light stimulation (BLS) was revealed to be beneficial for treating non-seasonal depression, although its mechanism of action is not fully understood. We developed a novel mouse model of refractory depression, induced through social isolation and chronic...

Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy

Annals of Punjab Medical College December 31, 2024 Mohammad Ali, Urbah Viqar

Background: The phenomenon of treatment-resistant depression (TRD) remains a problem in the sphere of mental health treatment since the majority of patients do not experience positive effects while receiving traditional treatments. Newer therapies are ketamine infusion therapy for depression, transcranial magnetic stimulation, and psilocybin-assisted psychotherapy give new hope. Objective: To...

Paradoxical Depressive Response to Intranasal Esketamine in Treatment-Resistant Depression: A Case Series.

The American journal of case reports December 28, 2024 Jose A Ontiveros-Sánchez de la Barquera, Luis Alberto De La Garza García, Silvia Viridiana Esquivel García et al. 2 citations

BACKGROUND Esketamine is the only pharmacological agent with glutamatergic neuromodulator properties approved by the US Food and Drug Administration and European Medicines Agency to enhance the effects of serotonin selective or serotonin and norepinephrine reuptake inhibitors. Treatment-resistant depression (TRD) is a challenging and prevalent condition in the psychiatric field, in which...

Ketamine and Esketamine in Treatment of Resistant Depression

Archiv Euromedica December 26, 2024 Jakub Prosowski, Szczepan Pośpiech, Michał Piotrowski et al.

Aims: This review aims to explore the efficacy, mechanisms, administration routes, and safety profiles of ketamine and esketamine in the treatment of treatment-resistant depression (TRD). Methods: A comprehensive review of recent studies on ketamine and esketamine’s therapeutic applications in TRD was conducted. Sources included randomized controlled trials, systematic reviews, and...

Merits and demerits of administering esketamine in preventing postpartum depression following cesarean section.

World Journal of Clinical Cases December 26, 2024 Takahiko Nagamine 1 citation

Emergency cesarean section is associated with the development of postpartum depression. Esketamine has been demonstrated to have a rapid onset of antidepressant effects. Randomized controlled trials and meta-analyses have demonstrated the efficacy of esketamine in preventing postpartum depression after cessarean section. However, the data included in these analyses were derived from elective...

DOI: 10.12998/wjcc.v12.i36.6883 (opens in new tab) Full text (opens in new tab) Esketamine Adverse event Cesarean section Medial prefrontal cortex +6

Depression, post-traumatic stress disorder, suicidal ideation and ketamine: a case report.

Journal of Medical Case Reports December 24, 2024 S Asad, K Latifzai, V T Eliopoulos et al. 1 citation

Ketamine treatment presents a novel approach for addressing refractory conditions, such as major depressive disorder, suicidal ideation, and posttraumatic stress disorder, which often co-occur and pose significant challenges for clinicians. This study explores the clinical and electrophysiological outcomes of ketamine treatment in two cases, shedding light on its potential efficacy and...

Ketamine Reduces Avoidance Responses During Re-Exposition to Aversive Stimulus: Comparison Between (S)-Isomer and Racemic Mixture.

Brain Sciences December 22, 2024 Clarissa A Moura, Anne N de Sousa-Silva, Ana Lívia Mesquita Soares et al. 1 citation

Recent studies have investigated the effects of ketamine on fear memory in animals. However, it is unclear if ketamine might affect avoidance memory and emotional behaviors concomitantly. In this study, we compared the effects of (R,S)- and (S)-ketamine in modulating avoidance responses, depression- and anxiety-related behaviors in stressed mice. Mice were previously exposed to inescapable...

DOI: 10.3390/brainsci14121291 (opens in new tab) Full text (opens in new tab) Animal model Aversive memory Mouse Ketamine therapy +4

Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review.

Progress in Neuro-Psychopharmacology and Biological Psychiatry December 20, 2024 Veronica Grasso, Gilmar Gutierrez, Najat Alzbeidi et al. 9 citations

Unipolar treatment-resistant depression (MDD-TRD) is associated with neurocognitive impairment. Ketamine, an emerging treatment for MDD-TRD, may have neurocognitive benefits, but evidence remains limited. We conducted a systematic search on EMBASE, Google Scholar, PsycINFO, and PubMed and included studies exploring the cognitive effects of intravenous (IV) ketamine treatment in the management...

DOI: 10.1016/j.pnpbp.2024.111095 (opens in new tab) Full text (opens in new tab) Major depressive disorder Intravenous ketamine Neurocognitive performance Treatment- resistant depression +5

Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammation.

Pharmacopsychiatry December 20, 2024 Mu-Hong Chen, Tung-Ping Su, Wei-Chen Lin et al. 1 citation

Low-grade inflammation (LGI) contributes to resistance against traditional antidepressants. However, whether the antidepressant and antisuicidal effects of ketamine on patients with treatment-resistant depression (TRD) differ between those with LGI and those without LGI remains unknown.This study included 167 patients with TRD, among whom 46 had LGI and 121 did not have LGI. The patients...

DOI: 10.1055/a-2499-7207 (opens in new tab) Full text (opens in new tab) Depression treatment Ketamine therapy Mental health Antidepressants +1

Beyond NMDA Receptors: A Narrative Review of Ketamine's Rapid and Multifaceted Mechanisms in Depression Treatment.

International Journal of Molecular Sciences December 20, 2024 Zuzanna Antos, Xawery Żukow, Laura Bursztynowicz et al. 14 citations

The rising prevalence of depression, with its associated suicide risk, demands effective fast-acting treatments. Ketamine has emerged as promising, demonstrating rapid antidepressant effects. While early studies show swift mood improvements, its precise mechanisms remain unclear. This article aims to compile and synthesize the literature on ketamine's molecular actions. Ketamine primarily works...